Schweizer MT - Search Results

1

Clinical determinants for successful circulating tumor DNA analysis in prostate cancer.

Schweizer MT, Gulati R, Beightol M, Konnick EQ, Cheng HH, Klemfuss N, De Sarkar N, Yu EY, Montgomery RB, Nelson PS, Pritchard CC. Schweizer MT, et al. Prostate. 2019 May;79(7):701-708. doi: 10.1002/pros.23778. Epub 2019 Mar 13. Prostate. 2019. PMID: 30865311 Free PMC article.

2

Clinical activity of enzalutamide versus docetaxel in men with castration-resistant prostate cancer progressing after abiraterone.

Suzman DL, Luber B, Schweizer MT, Nadal R, Antonarakis ES. Suzman DL, et al. Among authors: schweizer mt. Prostate. 2014 Sep;74(13):1278-85. doi: 10.1002/pros.22844. Epub 2014 Jul 22. Prostate. 2014. PMID: 25053178 Free PMC article.

3

Clinical activity of enzalutamide in Docetaxel-naïve and Docetaxel-pretreated patients with metastatic castration-resistant prostate cancer.

Nadal R, Zhang Z, Rahman H, Schweizer MT, Denmeade SR, Paller CJ, Carducci MA, Eisenberger MA, Antonarakis ES. Nadal R, et al. Among authors: schweizer mt. Prostate. 2014 Nov;74(15):1560-8. doi: 10.1002/pros.22874. Epub 2014 Aug 31. Prostate. 2014. PMID: 25176007 Free PMC article.

4

Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer.

Maughan BL, Xhou XC, Suzman DL, Nadal R, Bassi S, Schweizer MT, Antonarakis ES. Maughan BL, et al. Among authors: schweizer mt. Prostate. 2015 Nov;75(15):1814-20. doi: 10.1002/pros.23064. Epub 2015 Aug 26. Prostate. 2015. PMID: 26306637

5

Liquid biopsy: Clues on prostate cancer drug resistance.

Schweizer MT, Antonarakis ES. Schweizer MT, et al. Sci Transl Med. 2015 Nov 4;7(312):312fs45. doi: 10.1126/scitranslmed.aad4008. Sci Transl Med. 2015. PMID: 26537254

6

Persistent androgen receptor addiction in castration-resistant prostate cancer.

Schweizer MT, Yu EY. Schweizer MT, et al. J Hematol Oncol. 2015 Nov 13;8:128. doi: 10.1186/s13045-015-0225-2. J Hematol Oncol. 2015. PMID: 26566796 Free PMC article. Review.

7

Schweizer MT, Gulati R, Mostaghel EA, Nelson PS, Montgomery RB, Yu EY, Cheng HH. Schweizer MT, et al. Med Oncol. 2016 Jul;33(7):77. doi: 10.1007/s12032-016-0793-1. Epub 2016 Jun 14. Med Oncol. 2016. PMID: 27300548 Free PMC article.

8

A Pilot Study of Clinical Targeted Next Generation Sequencing for Prostate Cancer: Consequences for Treatment and Genetic Counseling.

Cheng HH, Klemfuss N, Montgomery B, Higano CS, Schweizer MT, Mostaghel EA, McFerrin LG, Yu EY, Nelson PS, Pritchard CC. Cheng HH, et al. Among authors: schweizer mt. Prostate. 2016 Oct;76(14):1303-11. doi: 10.1002/pros.23219. Epub 2016 Jun 21. Prostate. 2016. PMID: 27324988 Free PMC article.

9

Bipolar Androgen Therapy for Men With Androgen Ablation Naïve Prostate Cancer: Results From the Phase II BATMAN Study.

Schweizer MT, Wang H, Luber B, Nadal R, Spitz A, Rosen DM, Cao H, Antonarakis ES, Eisenberger MA, Carducci MA, Paller C, Denmeade SR. Schweizer MT, et al. Prostate. 2016 Sep;76(13):1218-26. doi: 10.1002/pros.23209. Epub 2016 Jun 24. Prostate. 2016. PMID: 27338150 Clinical Trial.

10

Targeting intratumoral androgens: statins and beyond.

Schweizer MT, Yu EY. Schweizer MT, et al. Ther Adv Med Oncol. 2016 Sep;8(5):388-95. doi: 10.1177/1758834016647962. Epub 2016 May 11. Ther Adv Med Oncol. 2016. PMID: 27583031 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters